Dr. Neil LoveUnclaimed
Host of Hematologic Oncology Update.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
As a guest
Dr. hosts Hematologic Oncology Update.
Written by PodSubs from Dr.'s credits.
PodCred record
PodCred is the verified record of where Dr. has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Dr. on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Dr. claims this profile.
Recommendations
Dr. has not written any yet.
Recommendations open once Dr. claims the profile.
Posts
No posts yet. Posts Dr. shares on PodSubs, and what Dr. publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on The Utility of Tafasitamab
Featuring an interview with Dr Matthew Lunning, including the following topics: Tafasitamab for follicular lymphoma (0:00) frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma...
Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line...
Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy...
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens
Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma - Ann LaCasce, MD, MMSc...
Diffuse Large B-Cell Lymphoma — A Grand Rounds Program
Featuring a presentation by Dr Matthew Matasar, including the following topics: Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00) Clinician Survey Results Regarding...
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis
Featuring an interview with Dr Matthew Lunning, including the following topics: A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP - Ann LaCasce, MD, MMSc (0:00) CNS prophylaxis in...
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Featuring perspectives from Dr Lindsey Roeker, including the following topics: Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line...
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 5
Featuring perspectives from Dr Lindsey Roeker, including the following topics: Consensus Approach to optimizing front-line treatment (0:00) Emerging role of sonrotoclax (8:39) Bruton tyrosine kinase inhibitor...
Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome
Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics:...
Chronic Lymphocytic Leukemia — Microlearning Activity 2
Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated...
